{"id":"SCV000062127","record_status":"current","date_created":"2013-03-16","variation_archive_id":"VCV000012610","interpretation_description":"Pathogenic","variation_id":"12610","rcv_accession_id":"RCV000013444","internal_id":"103327","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"The Thr58Ile variant in HRAS has been reported in three individuals with clinica l features of Costello syndrome (Gripp 2008, Gripp 2012, LMM unpublished data). It was identified to occur de novo in two of these individuals and segregated w ith disease in one affected relative from one of these families. This variant wa s absent from large population studies. Computational prediction tools and conse rvation analysis suggest that this variant may impact the protein, though this i nformation is not predictive enough to determine pathogenicity. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partner s.org/LMM).\"}"],"local_key":"26351883|Orphanet:ORPHA3071","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18247425\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22488832\",\"@Source\":\"PubMed\"}}]}}","submission_id":"21766.2019-03-21","trait_set_id":"3420","clinical_assertion_trait_set_id":"SCV000062127","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2014-09-23","clinical_assertion_observation_ids":["SCV000062127.0"],"date_last_updated":"2020-10-07","version":"5","submission_names":["SUB5348977"],"submitter_id":"21766","submitted_assembly":"GRCh37"}
{"id":"SCV000519504","record_status":"current","date_created":"2017-03-03","variation_archive_id":"VCV000003520","interpretation_description":"Benign","variation_id":"3520","rcv_accession_id":"RCV000428048","internal_id":"984917","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\"}"],"local_key":"GDX:570299|Not Provided","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-03-26","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV000519504","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2016-04-25","clinical_assertion_observation_ids":["SCV000519504.0"],"date_last_updated":"2020-10-08","version":"4","submission_names":["SUB3839901"],"submitter_id":"26957","submitted_assembly":"GRCh37"}
{"id":"SCV000884146","record_status":"current","date_created":"2019-02-15","variation_archive_id":"VCV000003520","interpretation_description":"Uncertain significance","variation_id":"3520","rcv_accession_id":"RCV000428048","internal_id":"1730401","review_status":"criteria provided, single submitter","interpretation_comments":[],"local_key":"74380|MedGen:CN169374","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","submission_id":"25969.2019-08-05","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV000884146","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2018-07-13","clinical_assertion_observation_ids":["SCV000884146.0"],"date_last_updated":"2020-10-06","version":"2","submission_names":["Aug 2019 ARUP"],"submitter_id":"25969","submitted_assembly":"not applicable"}
{"id":"SCV001157178","record_status":"current","date_created":"2020-02-07","variation_archive_id":"VCV000046503","interpretation_description":"Benign","variation_id":"46503","rcv_accession_id":"RCV000039762","internal_id":"2281510","review_status":"criteria provided, single submitter","interpretation_comments":[],"local_key":"121670|MedGen:CN169374","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","submission_id":"25969.2019-08-05","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV001157178","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2019-06-26","clinical_assertion_observation_ids":["SCV001157178.0"],"date_last_updated":"2020-10-06","version":"1","submission_names":["Aug 2019 ARUP"],"submitter_id":"25969","submitted_assembly":"not applicable"}
{"id":"SCV000063451","record_status":"current","date_created":"2013-03-16","variation_archive_id":"VCV000046503","interpretation_description":"Likely benign","variation_id":"46503","rcv_accession_id":"RCV000039762","internal_id":"104651","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"p.Ala1855Ala in exon 33 of PCDH15: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located ne ar a splice junction and has been identified in 0.3% (381/126618) European chro mosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute .org; dbSNP rs111033445).\"}"],"local_key":"30968208|not specified","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV000063451","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2017-09-04","clinical_assertion_observation_ids":["SCV000063451.0"],"date_last_updated":"2020-10-07","version":"6","submission_names":["SUB5348979"],"submitter_id":"21766","submitted_assembly":"GRCh37"}
{"id":"SCV000729392","record_status":"current","date_created":"2018-04-04","variation_archive_id":"VCV000046503","interpretation_description":"Likely benign","variation_id":"46503","rcv_accession_id":"RCV000039762","internal_id":"1410550","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\"}"],"local_key":"GDX:46979|Not Provided","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-03-26","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV000729392","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2017-11-21","clinical_assertion_observation_ids":["SCV000729392.0"],"date_last_updated":"2020-10-08","version":"1","submission_names":["SUB3839901"],"submitter_id":"26957","submitted_assembly":"GRCh37"}
{"id":"SCV000065162","record_status":"current","date_created":"2013-03-16","variation_archive_id":"VCV000048176","interpretation_description":"Uncertain significance","variation_id":"48176","rcv_accession_id":"RCV000041467","internal_id":"106362","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"The p.Arg544Cys variant in OTOF has been identified in 1 individual with autosom al recessive sensorineural hearing loss who carried a second OTOF variant of unc ertain significance; it is unclear whether these variants are in trans (Sommen 2 016). The p.Arg544Cys variant has also been identified by our laboratory in 6 in dividuals with hearing loss; however, none of these individuals carried a varian t affecting the other copy of the OTOF gene or was reported to have auditory neu ropathy typically associated with OTOF related hearing loss. This variant has be en reported in ClinVar (Variation ID: 48176). It has been identified in 0.15% (1 93/125430) of European chromosomes by the Genome Aggregation Database (gnomAD, h ttp://gnomad.broadinstitute.org); however, this frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation anal ysis suggest that the p.Arg544Cys variant may impact the protein, though this in formation is not predictive enough to determine pathogenicity. In summary, the c linical significance of the p.Arg544Cys variant is uncertain. ACMG/AMP Criteria applied: PP3, BS1_Supporting.\"}"],"local_key":"11832988|not specified","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV000065162","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2018-08-21","clinical_assertion_observation_ids":["SCV000065162.0"],"date_last_updated":"2020-10-07","version":"6","submission_names":["SUB5348979"],"submitter_id":"21766","submitted_assembly":"GRCh37"}
{"id":"SCV000429634","record_status":"current","date_created":"2016-12-02","variation_archive_id":"VCV000048176","interpretation_description":"Uncertain significance","variation_id":"48176","rcv_accession_id":"RCV000357820","internal_id":"743155","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.\"}"],"local_key":"231996|OMIM:601071","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification Criteria 13 December 2019\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/r0x0xrmc/icsl_variant_classification_criteria_13_december_2019.pdf\"}}}}","submission_id":"504895.2020-02-20","trait_set_id":"1697","clinical_assertion_trait_set_id":"SCV000429634","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2018-01-12","clinical_assertion_observation_ids":["SCV000429634.0"],"date_last_updated":"2020-06-01","version":"3","submission_names":["SUB6641900"],"submitter_id":"504895","submitted_assembly":"GRCh37"}
{"id":"SCV001159506","record_status":"current","date_created":"2020-02-07","variation_archive_id":"VCV000007884","interpretation_description":"Uncertain significance","variation_id":"7884","rcv_accession_id":"RCV000259072","internal_id":"2284080","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"The ABCA4 c.6148G\u003eC; p.Val2050Leu variant (rs41292677) is reported in the literature in multiple individuals affected with Stargardt disease, retinitis pigmentosa, or a related retinal disorder (Allikmets 1997, Corton 2013, Haer-Wigman 2017, Sciezynska 2016, Wiszniewski 2005). This variant has been observed in trans to a pathogenic variant in affected individuals (Corton 2013); however, it has also been observed in cis to a nonsense variant in at least one study (Sciezynska 2016). The p.Val2050Leu variant is found in the Latino population with an overall allele frequency of 0.60% (211/35438 alleles) in the Genome Aggregation Database and is reported with conflicting classifications in ClinVar (Variation ID: 7884). The leucine at codon 2050 is highly conserved, but computational analyses (SIFT: tolerated, PolyPhen-2: damaging) predict conflicting effects of this variant on protein structure/function. Due to conflicting information, the clinical significance of the p.Val2050Leu variant is uncertain at this time. References: Allikmets R et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997 Mar;15(3):236-46. Corton M et al. Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis. PLoS One. 2013 Jun 14;8(6):e65574. Haer-Wigman L et al. Diagnostic exome sequencing in 266 Dutch patients with visual impairment. Eur J Hum Genet. 2017 May;25(5):591-599. Sciezynska A et al. Next-generation sequencing of ABCA4: High frequency of complex alleles and novel mutations in patients with retinal dystrophies from Central Europe. Exp Eye Res. 2016 Apr;145:93-99. Wiszniewski W et al. ABCA4 mutations causing mislocalization are found frequently in patients with severe retinal dystrophies. Hum Mol Genet. 2005 Oct 1;14(19):2769-78.\"}"],"local_key":"349329|MedGen:CN169374","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","submission_id":"25969.2019-08-05","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV001159506","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2019-04-09","clinical_assertion_observation_ids":["SCV001159506.0"],"date_last_updated":"2020-10-06","version":"1","submission_names":["Aug 2019 ARUP"],"submitter_id":"25969","submitted_assembly":"not applicable"}
{"id":"SCV000061597","record_status":"current","date_created":"2013-03-16","variation_archive_id":"VCV000013972","interpretation_description":"Pathogenic","variation_id":"13972","rcv_accession_id":"RCV000037932","internal_id":"102797","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"This variant has been reported as a somatic change in large intestine, skin, end ometrium, stomach, and ovary (COSMIC, Fransen 2004) and has been observed in up to 11% of BRAF mutant positive lung adenocarcinoma (Paik 2011).\"}"],"local_key":"15072993|MeSH:D002289","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"14688025\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","trait_set_id":"4069","clinical_assertion_trait_set_id":"SCV000061597","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2012-06-11","clinical_assertion_observation_ids":["SCV000061597.0"],"date_last_updated":"2020-10-07","version":"4","submission_names":["SUB5348977"],"submitter_id":"21766","submitted_assembly":"GRCh37"}
{"id":"SCV001365521","record_status":"current","date_created":"2020-06-29","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV001195214","internal_id":"2693418","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"APC c.3920T\u003eA (p.Ile1307Lys, also known as I1307K) has been associated with colorectal cancer. This variant has been observed in multiple ethnic backgrounds with highest frequencies in individuals of Ashkenazi Jewish ancestry (3.6% Genome Aggregation Database (gnomAD); rs1801155) and is present in ClinVar (ID: 822). Several large studies and meta-analyses have reported odds ratios 1.51-2.53 for developing colorectal cancer in Ashkenazi Jewish population (OR=1.51 [95% CI 1.16-1.98] Boursi 2013, OR=2.17 [95% CI 1.64-2.86] Liang 2013, OR=2.53 [95% CI 2.11-3.04] Leshno 2016). However, the cancer risk remains unknown in individuals of non-Jewish descent. This variant introduces a polyA(8) region that is subject to slippage during DNA replication, which increases the susceptibility for somatic changes (Laken 1997, Gryfe 1998). In summary, this variant is an established risk factor for colorectal cancer.\"}"],"local_key":"56643454|MedGen:C1527249","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}}]}}","submission_id":"21766.2020-05-14","trait_set_id":"20218","clinical_assertion_trait_set_id":"SCV001365521","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2020-03-04","clinical_assertion_observation_ids":["SCV001365521.0"],"date_last_updated":"2020-10-07","version":"1","submission_names":["SUB7448406"],"submitter_id":"21766","submitted_assembly":"GRCh37"}
{"id":"SCV000148996","record_status":"current","date_created":"2014-05-13","variation_archive_id":"VCV000000822","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000034388","internal_id":"269650","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"This variant is denoted APC c.3920T\u003eA at the DNA level and p.Ile1307Lys (I1307K) at the protein level, replacing an Isoleucine with a Lysine. APC Ile1307Lys is a common variant, observed at an allele frequency of 3.7% (371/10,138) in individuals of Ashkenazi Jewish ancestry in large population cohorts (Lek 2016) and in up to 11% of individuals in Ashkenazi Jewish cohorts in the literature (Liang 2013, Boursi 2013). A meta-analysis of epidemiologic studies of APC polymorphisms suggests that individuals of Ashkenazi Jewish ancestry who carry this variant have a 2-fold increased risk of colorectal cancer (Liang 2013). However, studies of this variant in other populations did not report an increased risk of colorectal cancer (Liang 2013); therefore, the clinical significance in individuals without Jewish ancestry is not clear at this time. In sum, we consider APC Ile1307Lys to be a risk allele. The National Comprehensive Cancer Network has management guidelines for individuals carrying the APC Ile1307Lys risk allele (NCCN).\"}"],"local_key":"GDX:3786|Not Provided","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-09-07","trait_set_id":"9460","clinical_assertion_trait_set_id":"SCV000148996","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2015-05-08","clinical_assertion_observation_ids":["SCV000148996.0"],"date_last_updated":"2020-10-08","version":"4","submission_names":["SUB4498316"],"submitter_id":"26957","submitted_assembly":"GRCh37"}
{"id":"SCV000807826","record_status":"current","date_created":"2018-09-20","variation_archive_id":"VCV000000822","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000238802","internal_id":"1575248","review_status":"criteria provided, single submitter","interpretation_comments":[],"local_key":"APC-B1|MedGen:CN240755","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","submission_id":"1024.2018-07-17","trait_set_id":"8942","clinical_assertion_trait_set_id":"SCV000807826","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2018-06-01","clinical_assertion_observation_ids":["SCV000807826.0"],"date_last_updated":"2020-10-08","version":"1","submission_names":["SUB4304907"],"submitter_id":"1024","submitted_assembly":"GRCh38"}
{"id":"SCV000711777","record_status":"current","date_created":"2018-04-03","variation_archive_id":"VCV000504895","interpretation_description":"Likely benign","variation_id":"504895","rcv_accession_id":"RCV000614433","internal_id":"1392883","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"c.2232+9C\u003eT in intron 18 of MYH14: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence.\"}"],"local_key":"66138958|not specified","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV000711777","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2016-04-14","clinical_assertion_observation_ids":["SCV000711777.0"],"date_last_updated":"2020-10-07","version":"1","submission_names":["SUB5348977"],"submitter_id":"21766","submitted_assembly":"GRCh37"}
{"id":"SCV000604327","record_status":"current","date_created":"2017-09-27","variation_archive_id":"VCV000042540","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV001000015","internal_id":"1168023","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant (rs375882485) is a well-known causative variant reported in multiple individuals with hypertrophic cardiomyopathy (HCM; Richard 2003, Maron 2008, Kaski 2012, and Lopez 2013), and shown to segregate with disease in at least one affected family (Camuglia 2013). In one large study, the p.Arg502Trp variant was identified in 2.4% of Caucasian HCM patients (Saltzman 2010). This variant was also found at 1.4% in 6179 individuals diagnosed with HCM (Walsh 2017). Nuclear magnetic resonance studies indicate that p.Arg502Trp may impair important electrostatic interactions between MYBPC3 protein and other sarcomeric proteins (Zhang 2014). Thus, the p.Arg502Trp variant meets our criteria for classification as pathogenic.\"}"],"local_key":"118047|MedGen:CN169374","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","submission_id":"25969.2019-08-05","trait_set_id":"9590","clinical_assertion_trait_set_id":"SCV000604327","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2019-04-07","clinical_assertion_observation_ids":["SCV000604327.0"],"date_last_updated":"2020-10-06","version":"3","submission_names":["Aug 2019 ARUP"],"submitter_id":"25969","submitted_assembly":"not applicable"}
{"id":"SCV001433438","record_status":"current","date_created":"2020-09-23","variation_archive_id":"VCV000042540","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000584810","internal_id":"2830323","review_status":"criteria provided, single submitter","interpretation_comments":[],"local_key":"NM_000256.3:c.1504C\u003eT","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"505816.2020-07-24","trait_set_id":"6411","clinical_assertion_trait_set_id":"SCV001433438","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2019-02-18","clinical_assertion_observation_ids":["SCV001433438.0"],"date_last_updated":"2020-09-27","version":"1","submission_names":["SUB7802809"],"submitter_id":"505816","submitted_assembly":"GRCh37"}
{"id":"SCV000059054","record_status":"current","date_created":"2013-03-16","variation_archive_id":"VCV000042540","interpretation_description":"Pathogenic","variation_id":"42540","rcv_accession_id":"RCV000203913","internal_id":"100254","review_status":"criteria provided, single submitter","interpretation_comments":["{\"text\":\"The p.Arg502Trp variant in MYBPC3 is a known pathogenic variant for hypertrophic cardiomyopathy (HCM). It has been reported across multiple studies in \u003e150 individuals with HCM and has been shown to segregated with disease in multiple families (Richard 2003, Van Driest 2004, Carballo 2005, Ingles 2005, Maron 2008, Kaski 2009, Marston 2009, Saltzman 2010, Walsh 2016, LMM data). In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant HCM. ACMG/AMP criteria applied: PS4, PP1_Strong.\"}"],"local_key":"2991309|Orphanet:ORPHA217569","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}],\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"27532257\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16199542\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15519027\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12707239\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20378854\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19574547\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18809796\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20031618\",\"@Source\":\"PubMed\"}}]},\"ReplacedList\":{\"Replaced\":{\"@Accession\":\"SCV000198910\",\"@DateChanged\":\"2015-02-23\",\"@Version\":\"1\"}}}","submission_id":"21766.2020-06-03","trait_set_id":"17368","clinical_assertion_trait_set_id":"SCV000059054","assertion_type":"variation to disease","interpretation_date_last_evaluated":"2019-08-29","clinical_assertion_observation_ids":["SCV000059054.0"],"date_last_updated":"2020-10-07","version":"6","submission_names":["SUB7546315"],"submitter_id":"21766","submitted_assembly":"GRCh37"}
